The TAX 324 trial showed that the proportion of HPV positive oropharyngeal tumors was nine times higher in white versus black patients. HPV positive tumors exhibited a dramatically improved overall survival leading to an overall improved survival rate in white versus black patients. To confirm the racial disparity observed in Tax324 we performed a retrospective analysis in a larger sample size of 480 patients with oropharyngeal cancer treated at a single institution between 1995 and 2007. HPV-16 status was evaluated by PCR of DNA extracted from pretreatment biopsies embedded in paraffin. RESULTS: Among the 480 patients, detailed clinical information is available for 288 patients, and HPV status is known for 155 patients. 56% of patients are white and 44% are black. 84% of the patients are male. Median age is 56. The majority of patients (64%) are stage IV. Of patients with informative HPV samples, 40/95 (42%) of white patients are HPV positive while only 7 of 60 black patients (12%) are HPV positive (pϽ0.0001). CONCLUSION: This independent data set confirms the Tax324 trial observation that the prevalence of HPV positive oropharyngeal cancers is much lower in blacks than in whites. Together with the markedly favorable prognosis of HPV positive compared to HPV negative patients, this difference contributes significantly to overall racial survival disparities in oropharyngeal cancer.
OBJECTIVE:
To assess the histologic effects of induction chemotherapy in patients with osteosarcoma of the head and neck, treated surgically at Royal Melbourne Hospital. METHOD: Retrospective chart review of 23 head and neck osteosarcomas treated between January 1992 and January 2010. Induction chemotherapy was used in 13 cases and surgery alone in 10. Histology slides were reviewed by a senior pathologist. RESULTS: 13 patients underwent induction chemotherapy for 2 cycles followed by surgical resection then consolidation chemotherapy for 4 cycles. Free flap reconstruction was performed in 20 cases, 11 following induction chemotherapy. Nine patients completed the full course of chemotherapy, with 4 stopping due to side effects. Histology showed good response (Ͼ50% kill) in 1 patient, partial response (10-50% cell kill) in 2 patients and no response in 10 patients (77%). Surgical delay occurred in 4 patients (31%) due to bone marrow toxicity. Minor complications occurred in 5 patients and major in 1 patient in the chemotherapy group, similar to the surgery alone group. Local recurrence and survival was similar in the chemotherapy and surgery. CONCLUSION: Induction chemotherapy does not seem to have a significant effect in tumor reduction when used pre operatively. We believe that surgical resection of the tumor and reconstruction with post operative chemotherapy is a better management option for these patients as it avoids delays and the unavoidable increase of tumor size.
Results of a Community Based Head and Neck Cancer Screening
Justin Wise, PhD (presenter)
OBJECTIVE:
The overall aim of this study was to examine the usefulness of a large scale head and neck cancer screening for reducing smoking behavior in an at-risk population (i.e., NASCAR fans). METHOD: Participants were recruited from NASCAR fans touring the midway before entry into the race venue. Individuals who agreed to undergo a free head and neck cancer screening were given an initial survey and were directed to a tent to undergo a head and neck screening by a healthcare professional who specialized in the detection of head and neck cancer. At six months post-screening, those individuals that reported current use of tobacco were contacted by phone and given a phone interview survey. RESULTS: A 2 (screening findings) X 2 (time point) repeated measures ANOVA indicated that overall, participants reported smoking significantly less cigarettes per day (M ϭ 13.78) at the six month follow up compared to the number of cigarettes (M ϭ 19.43) smoked at the baseline time point, F (1, 72) ϭ 31.86, p Ͻ .001, ?2 ϭ .31. Forty-four (59%) participants reported reducing the number of cigarettes they smoked per day and 11 participants reported quitting smoking. CONCLUSION: Results from this study indicate that a largescale community-based head and neck cancer screening can effectively be implemented in nonmedical venues. Findings from this study targeting education to reduce smoking behavior indicated that 6 months post screening, participants reported smoking significantly less cigarettes per day. This was true in both those with concerning signs or symptoms for head and neck cancer and those with normal exams. ORALS an ethically approved prospective study conducted at a tertiary referral endocrine center in the UK. Intra-operative outcome measures included procedure time and blood loss. Postoperative measures included biochemical and histopathological assessment. Patient-reported outcome measures (PROMS) included subjective assessment of pain and scar cosmesis using Visual analogue scores, Voice Disability Index 2 and EQ5 HD quality of life assessment recorded 1 day, 2 weeks, 3 and 6 months postoperatively. RESULTS: In all cases the parathyroid adenoma was successfully identified and removed. Blood loss was negligible (Ͻ5 ml). The recurrent laryngeal nerve (RLN) was identified and preserved in all cases. Mean robot docking and closure times plateaued to 19 minutes and 24 minutes respectively. The mean robotic console time was 65 minutes (range 25-105 minutes). Factors determining the console time were body habitus, size of the parathyroid adenoma and surgical access. Postoperative pain was minimal in the post-op period and disappeared thereafter. Subjective voice assessment showed no change in voice quality. All EQ5 HD quality of life parameters significantly improved (pϽ0.05). Patients were discharged on the 1st post operative day. Mean time to return to daily activities was 3.4 days. CONCLUSION: Robotic assisted parathyroidectomy represents a novel targeted "scar-less in the neck" surgical approach. Preliminary results suggest improved patient satisfaction, minimal postoperative pain and rapid return to daily activities.
Robotic Assisted Parathyroidectomy

Sentinel Node Biopsy for Head and Neck Melanoma: A Systematic Review
Nicole de Rosa, MD (presenter); Gary H Lyman, MD, MPH; Damian Silbermins, MD; Matias Valsecchi, MD; Walter Lee, MD OBJECTIVE: 1) Determine test performance of sentinel node biopsy (SNB) in head and neck (H&N) melanoma. 2) Calculate SNB identification and false negative rate. METHOD: A systematic literature review of studies between 1990-2009 was performed. Dual blind data extraction was conducted. Primary outcomes included identification rates and test performance based on completion neck dissection (CND) or nodal recurrence. RESULTS: Eligibility criteria were met for 32 studies (2,694 patients). Enrollment varied from 9 to 629 patients (median 55). Mean Breslow was 2.53 mm (range 0.02 mm to 20 mm). The median SNB identification rate was 95.7% (range 12% to 100%). More than 1 basin was reported in 33.1% of patients. A median of 2.56 sentinel nodes per patient were excised. In 17.1% of patients, SNB were positive. Additional positive nodes were found in 22.5% of patients that underwent CND. Median follow-up time was 30 months (range 1 to 125). Among patients with negative SNB, recurrent disease was reported in 12%, including 2.2% in the nodal basin. The false negative rate for nodal recurrence was reported in 24 studies with a median 10.7%. Among patients with a positive SNB, recurrent disease was reported in 62.5%, including 14.1% in the nodal basin. CONCLUSION: SNB of H&N melanoma has an identification rate of 95.7% with 10.7% false negative rate and is comparable to SNB of non-H&N melanoma. However, unique aspects of SNB for H&N melanoma include 33.1% of patients have sentinel nodes in multiple basins and 62.5% of patients with positive SNB experience tumor recurrence.
Sentinel Node Biopsy in Thyroid Cancer: Does it Work?
Sumeet Anand, MSc, MD (presenter); Richard Payne, MD; Olga Gologan, MD; Louise Rochon, MD OBJECTIVE: To prospectively review the role of sentinel lymph node (SLN) biopsy in the management of well differentiated thyroid carcinoma (WDTC), and determine whether frozen section analysis accurately predicts the status of the SLN. Our study assesses, first, whether specific lymph nodes (SLN) consistently receive malignant cells from a thyroid carcinoma and, second, whether a negative SLN on frozen section reliably predicts a disease-free central compartment. METHOD: SLN biopsy was performed on consecutive patients undergoing thyroidectomy at the McGill University Thyroid Cancer Center in Montreal, Canada. Nodules were injected with 0.3ccs of methylene blue. A central compartment neck dissection was performed. Lymph nodes that stained blue were considered as SLNs. Frozen section analysis of the SLNs was performed. RESULTS: 237 patients underwent SLN biopsy and central compartment neck dissection. 103 patients had WDTC. 75% (77/103) of patients were found to have detectable SLNs. No patients (0/26) with undetectable SLNs were found to have central compartment metastasis. 29% (22 of 77) of patients had positive SLNs for metastasis. A negative SLN corresponded with a negative central compartment 98% of the time (54/55, sensitivity 98%, p-value Ͻ0.05). Frozen section was able to detect metastasis in 91% (10/11) of patients' SLNs. CONCLUSION: Our data shows that a negative SLN on final pathology correlates strongly with a negative central compartment. Frozen section is an accurate method to determine the status of the SLN. This series shows that if a patient has benign SLNs, a central compartment neck dissection can be spared.
Snail as a Novel Marker for Regional Metastasis in HNSCC
Maie St John, MD, PhD (presenter); Elliot Abemayor, MD, PhD OBJECTIVE: Previous studies have shown Snail expression integral to the epithelial-mesenchymal transition during tumor progression. However, its behavior in clinical head & neck
